Purity numbers on an NMN label are only meaningful next to a real certificate of analysis.
Nicotinamide mononucleotide (NMN) sits behind most modern NAD+ supplementation claims, and almost every bottle on the market advertises a purity figure somewhere on the front panel: 98%, 99%, 99.9%. Shoppers treat this like a single quality score. It is not. Purity tells you how much of the capsule is actually NMN versus processing residue, but it says nothing about dose, stability, or whether the study evidence behind NMN even applies to what you bought.
What the Purity Number Is Actually Measuring
NMN is manufactured via enzymatic or chemical synthesis, and both routes leave behind residual solvents, unreacted precursors, and related nucleotides. HPLC purity testing quantifies how much of the sample is NMN itself. A 99.9% purity certificate means less than 0.1% of the tested batch is something other than NMN — not that the product works 0.9% better than a 99% batch.
Below roughly 98% purity, you start seeing meaningful amounts of nicotinamide riboside intermediates or synthesis byproducts, which is the threshold most reputable suppliers use as their cutoff. Above that, the differences are mostly cosmetic marketing rather than functional.
Dose Range With Actual Human Trial Support
Human NMN trials (Yoshino et al. 2021; Igarashi et al. 2022; Katayoshi et al. 2023) have used daily doses between 250 mg and 900 mg, with most positive signal for insulin sensitivity and NAD+ blood markers clustering around 250–500 mg/day taken consistently for 8–12 weeks. Products dosed well below 250 mg per serving are unlikely to replicate trial outcomes regardless of purity.
- Below 125 mg/day: below every published trial dose — treat as a starter dose only.
- 250–500 mg/day: the range with the most consistent human data.
- Above 900 mg/day: outside current trial ranges; no evidence it does more, and cost scales linearly for no proven benefit.
Reading a Certificate of Analysis (COA)
A real COA lists the testing lab, batch number, HPLC purity result, and heavy metal / microbial screening — not just a purity percentage pasted onto the product page. If a brand cannot produce a batch-specific COA on request, the purity claim on the label is unverifiable marketing copy.
Why the Marketing Focuses on Purity Instead of Dose
Purity is a single number that is easy to print in bold on a product page and easy for a shopper to compare at a glance. Dose response is harder to market because it requires explaining trial protocols, and honest dosing sometimes means a smaller serving count per bottle than a competitor padding capsules with filler. A brand that wants to look premium without doing the harder work of trial-aligned dosing will lean on the purity number because it photographs well and needs no further explanation. That does not make purity meaningless — it just means it is being used to do more marketing work than it is actually capable of doing.
How NMN Purity Testing Actually Works
Reputable manufacturers send finished batches to an independent lab for HPLC (high-performance liquid chromatography) analysis, which separates the sample into its component compounds and measures the relative concentration of each. The output is a chromatogram showing one large peak for NMN and smaller peaks for anything else present — unreacted precursor molecules, related nucleotides like NR or NAD+ itself, and trace solvents from the synthesis process. A lab report worth trusting states the testing method, the equipment used, and a batch or lot number that ties the result to the specific product you are holding, not a generic percentage the brand reuses across every batch it ships.
Why Dose Consistency Matters More Than People Expect
NAD+ precursor supplementation research consistently shows that intermittent or inconsistent dosing produces weaker outcomes than steady daily intake over the same total study window. This is a slow-building supplement category, closer to how creatine or vitamin D behave than a fast-acting stimulant. Skipping several days a week, even while keeping the per-dose amount correct, meaningfully undercuts the blood marker changes seen in the trials this article cites. If cost or capsule count is pushing someone toward a lower, less-than-trial dose taken daily instead of a full trial dose taken inconsistently, the daily lower dose is generally the better tradeoff for building steady NAD+ support.
What to Avoid
- Proprietary blends that bury NMN inside a "NAD+ complex" without a standalone dose figure.
- Purity claims with no lab name or batch number attached.
- Serving sizes under 100 mg marketed at trial-level pricing.
- Marketing copy that implies a specific purity percentage produces a specific extra benefit, since no published trial has isolated purity as an independent variable this way.
- Bottles that change their advertised purity number between production runs without a dated, batch-specific certificate to back the change up.
Frequently Asked Questions
Is 99.9% purity meaningfully better than 99%?
Not functionally. Both are well above the threshold where synthesis byproducts matter. The purity gap between them is smaller than normal batch-to-batch variation.
What dose of NMN do the human studies actually use?
Most positive-outcome trials used 250–500 mg/day for 8 weeks or longer. Shorter or lower-dose protocols have weaker or null results.
Does NMN need to be taken with anything?
No fasting or cofactor requirement is established in the trial literature; consistency of daily dosing matters more than timing.
Can purity below 98% still be safe?
Not necessarily unsafe, but it is a signal the manufacturer is either using a lower-cost synthesis route or has not invested in the additional purification step, and it makes contamination with unlisted byproducts more likely over a large batch. It is a reasonable cutoff to screen products against rather than a hard safety line on its own.
Does capsule versus powder form change how purity or dose matters?
No — purity and dose are properties of the raw NMN itself, not the delivery format. Powder gives more flexibility to titrate dose precisely; capsules are more convenient and consistent serving to serving, which matters more for the daily-consistency point above than the format itself does.
The Bottom Line
Purity above 99% is a baseline quality signal, not a performance lever. Dose in the 250–500 mg range with a verifiable, batch-specific COA is the actual differentiator between a supplement built on trial data and one built on a marketing percentage.
